Novavax and Serum Institute of India Receive Emergency Use Authorization for COVID-19 Vaccine in Indonesia
Go back to Novavax and Serum Institute of India Receive Emergency Use Authorization for COVID-19 Vaccine in Indonesia| Novavax, Inc. (NASDAQ: NVAX) | Delayed: 9.85 -0.34 (3.34%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $10.19 | 52 Week High | $9.23 | |||
| Open | $10.02 | 52 Week Low | $1.16 | |||
| Day High | $10.24 | P/E | N/A | |||
| Day Low | $9.73 | EPS | $-0.30 | |||
| Volume | 4,281,670 | |||||
